Literature DB >> 10198599

Early rehabilitation program in postmastectomy patients: a prospective clinical trial.

Y M Na1, J S Lee, J S Park, S W Kang, H D Lee, J Y Koo.   

Abstract

The purpose of this study was to determine whether 20 patients who received an early postmastectomy rehabilitation treatment program showed more improvement in range of shoulder motion and functional activities than 13 patients who received instruction for exercise only. Data were obtained at preoperatively, three days after operation, at discharge and at postdischarge one month for each patient on parameters such as range of motion of the ipsilateral shoulder joint, upper extremity circumferential measurements, as well as 10 elements of shoulder function. Postoperatively, both groups showed an increased range of motion of the shoulder joint and improved functional activities, but the group that received postoperative rehabilitation management had a better range of shoulder motion and less difficulty in five items for functional assessment. This study also showed that an early rehabilitation program did not increase postoperative complications. We concluded that an early rehabilitation program or intensive instruction program only by a well-trained physical therapist or physiatrist was beneficial to postmastectomy patients in regaining the function and range of shoulder motion, and significantly better in a rehabilitation group.

Entities:  

Mesh:

Year:  1999        PMID: 10198599     DOI: 10.3349/ymj.1999.40.1.1

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  8 in total

Review 1.  Multidisciplinary rehabilitation for follow-up of women treated for breast cancer.

Authors:  Fary Khan; Bhasker Amatya; Louisa Ng; Marina Demetrios; Nina Y Zhang; Lynne Turner-Stokes
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

2.  Accessory Joint and Neural Mobilizations for Shoulder Range of Motion Restriction After Breast Cancer Surgery: A Pilot Randomized Clinical Trial.

Authors:  Irene de la Rosa Díaz; María Torres Lacomba; Ester Cerezo Téllez; Cristina Díaz Del Campo Gómez-Rico; Carlos Gutiérrez Ortega
Journal:  J Chiropr Med       Date:  2016-11-23

3.  Feasibility of an Exercise Program for Puerto Rican Women who are Breast Cancer Survivors.

Authors:  Ana L Mulero Portela; Carmen L Colón Santaella; Cynthia Cruz Gómez; Annlee Burch
Journal:  Rehabil Oncol       Date:  2008-04-01

4.  The effect of rehabilitation on quality of life in female breast cancer survivors in Iran.

Authors:  M Poorkiani; A Abbaszadeh; M Hazrati; P Jafari; M Sadeghi; M Mohammadianpanah
Journal:  Indian J Med Paediatr Oncol       Date:  2010-10

5.  The Influence of Soft Tissue Therapy on Respiratory Efficiency and Chest Mobility of Women Suffering from Breast Cancer.

Authors:  Katarzyna Domaszewska; Tomasz Pieńkowski; Arkadiusz Janiak; Dorota Bukowska; Maria Laurentowska
Journal:  Int J Environ Res Public Health       Date:  2019-12-13       Impact factor: 3.390

Review 6.  Conservative interventions and clinical outcome measures used in the perioperative rehabilitation of breast cancer patients undergoing mastectomy: a scoping review.

Authors:  Janny Mathieu; Catherine Daneau; Nadège Lemeunier; Annabelle Doyon; Andrée-Anne Marchand; Martin Descarreaux
Journal:  BMC Womens Health       Date:  2022-08-16       Impact factor: 2.742

7.  Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial.

Authors:  María Torres Lacomba; María José Yuste Sánchez; Alvaro Zapico Goñi; David Prieto Merino; Orlando Mayoral del Moral; Ester Cerezo Téllez; Elena Minayo Mogollón
Journal:  BMJ       Date:  2010-01-12

8.  Shoulder Mobility, Muscular Strength, and Quality of Life in Breast Cancer Survivors with and without Tai Chi Qigong Training.

Authors:  Shirley S M Fong; Shamay S M Ng; W S Luk; Joanne W Y Chung; Louisa M Y Chung; William W N Tsang; Lina P Y Chow
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-23       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.